2.80Open4.12Pre Close6 Volume56 Open Interest74.00Strike Price1.68KTurnover50.89%IV0.51%PremiumDec 20, 2024Expiry Date2.41Intrinsic Value100Multiplier3DDays to Expiry0.39Extrinsic Value100Contract SizeAmericanOptions Type0.7540Delta0.0842Gamma25.47Leverage Ratio-0.1888Theta0.0051Rho19.20Eff Leverage0.0232Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet